Dimensional Fund Advisors LP Has $1.05 Million Stock Position in PetMed Express, Inc. (NASDAQ:PETS)

Dimensional Fund Advisors LP raised its holdings in PetMed Express, Inc. (NASDAQ:PETS) by 2.1% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 216,812 shares of the company’s stock after purchasing an additional 4,410 shares during the quarter. Dimensional Fund Advisors LP’s holdings in PetMed Express were worth $1,045,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently bought and sold shares of PETS. R Squared Ltd acquired a new position in shares of PetMed Express in the fourth quarter valued at approximately $31,000. Virtu Financial LLC acquired a new stake in shares of PetMed Express in the 4th quarter valued at $58,000. Diametric Capital LP acquired a new stake in shares of PetMed Express in the 4th quarter valued at $86,000. Blair William & Co. IL lifted its stake in shares of PetMed Express by 95.2% in the 4th quarter. Blair William & Co. IL now owns 20,300 shares of the company’s stock valued at $98,000 after acquiring an additional 9,900 shares during the last quarter. Finally, American Century Companies Inc. lifted its stake in shares of PetMed Express by 15.3% in the 4th quarter. American Century Companies Inc. now owns 33,662 shares of the company’s stock valued at $162,000 after acquiring an additional 4,459 shares during the last quarter. Institutional investors own 73.33% of the company’s stock.

Insider Buying and Selling at PetMed Express

In related news, CEO Sandra Yvette Campos sold 60,463 shares of the stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $3.31, for a total value of $200,132.53. Following the completion of the transaction, the chief executive officer now directly owns 578,524 shares of the company’s stock, valued at $1,914,914.44. This represents a 9.46% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Company insiders own 1.10% of the company’s stock.

Analyst Ratings Changes

Several research analysts have recently weighed in on PETS shares. StockNews.com lowered PetMed Express from a “buy” rating to a “hold” rating in a research report on Wednesday, May 7th. Morgan Stanley cut their target price on PetMed Express from $3.50 to $3.20 and set an “underweight” rating on the stock in a research note on Thursday, April 17th.

PetMed Express Stock Performance

PetMed Express stock opened at $3.76 on Friday. The stock has a market cap of $77.67 million, a P/E ratio of 376.38 and a beta of 0.76. PetMed Express, Inc. has a fifty-two week low of $2.90 and a fifty-two week high of $6.85. The firm’s fifty day moving average price is $3.63 and its 200-day moving average price is $4.43.

PetMed Express (NASDAQ:PETS) last announced its earnings results on Monday, February 10th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by ($0.02). PetMed Express had a return on equity of 0.37% and a net margin of 0.14%. Sell-side analysts predict that PetMed Express, Inc. will post 0.19 earnings per share for the current year.

PetMed Express Profile

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.